Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McMaster University

$105,000.00

The Effect of Slit2 on Retinal Ganglion Cell Survival After Optic Nerve Crush Injury

FY 2011-12

Summary
Glaucoma is a leading cause of irreversible blindness worldwide. Blindness in glaucoma is a result of the death of retinal ganglion cells over time in the eye. Retinal ganglion cells transmit the signals received by the retina, through the optic nerve, to the brain. The cause of death of retinal ganglion cells in glaucoma is unknown. One theory involves the immune system as a main player in the progression of disease in glaucoma. Slit2 is a protein that has been shown to inhibit immune cell migration and chemotaxis in vitro. It has also shown to have an anti-inflammatory effect in vivo in an animal model of kidney disease. The use of other anti-inflammatory drugs such as minocycline has shown to significantly improve retinal ganglion cell survival after optic nerve injury in animal models. The effect of Slit2 on retinal ganglion cell survival will be determined by injecting Slit2 following optic nerve crush injury. Retinal ganglion cells die over a four week period following optic nerve crush injury. Surviving retinal ganglion cells will be counted and compared to animals that did not receive treatment. It is anticipated that Slit2 will improve the survival of retinal ganglion cells after injury. Understanding the mechanisms of retinal ganglion cell death and the role of Slit2 can increase our knowledge about glaucoma and identify novel therapies to slow or fully stop the progression of this and other ocular diseases.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
257538
Name
Sabljic Thomas
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
The Effect of Slit2 on Retinal Ganglion Cell Survival After Optic Nerve Crush Injury
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Fluorescence Microscopy; Immunohistochemistry; Microsurgery; Neuronal Regeneration; Neuronal Survival
Abstract
Glaucoma is a leading cause of irreversible blindness worldwide. Blindness in glaucoma is a result of the death of retinal ganglion cells over time in the eye. Retinal ganglion cells transmit the signals received by the retina, through the optic nerve, to the brain. The cause of death of retinal ganglion cells in glaucoma is unknown. One theory involves the immune system as a main player in the progression of disease in glaucoma. Slit2 is a protein that has been shown to inhibit immune cell migration and chemotaxis in vitro. It has also shown to have an anti-inflammatory effect in vivo in an animal model of kidney disease. The use of other anti-inflammatory drugs such as minocycline has shown to significantly improve retinal ganglion cell survival after optic nerve injury in animal models. The effect of Slit2 on retinal ganglion cell survival will be determined by injecting Slit2 following optic nerve crush injury. Retinal ganglion cells die over a four week period following optic nerve crush injury. Surviving retinal ganglion cells will be counted and compared to animals that did not receive treatment. It is anticipated that Slit2 will improve the survival of retinal ganglion cells after injury. Understanding the mechanisms of retinal ganglion cell death and the role of Slit2 can increase our knowledge about glaucoma and identify novel therapies to slow or fully stop the progression of this and other ocular diseases.
Competitiondate
201110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Sabljic, Thomas
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
McMaster University - $105,000 Grant (2011-12) | Canada Spends